NAVXCELL

Serial Number 97436707
Registration 7134753
700

Registration Progress

Application Filed
May 31, 2022
Under Examination
Nov 29, 2022
Approved for Publication
Oct 4, 2022
Published for Opposition
Oct 4, 2022
Registered
Aug 8, 2023

Trademark Image

NAVXCELL

Basic Information

Serial Number
97436707
Registration Number
7134753
Filing Date
May 31, 2022
Registration Date
August 8, 2023
Published for Opposition
October 4, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 8, 2023
Registration
Registered
Classes
005

Rights Holder

REGENXBIO Inc.

03
Address
9804 Medical Center Drive
Rockville, MD 20850

Ownership History

REGENXBIO Inc.

Original Applicant
03
Rockville, MD

REGENXBIO Inc.

Owner at Publication
03
Rockville, MD

REGENXBIO Inc.

Original Registrant
03
Rockville, MD

Legal Representation

Attorney
William R. Samuels

USPTO Deadlines

Next Deadline
1482 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-08-08)
Due Date
August 08, 2029
Grace Period Ends
February 08, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Dec 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 8, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 8, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 6, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 5, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 20, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 17, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 17, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 16, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 24, 2023 IUAF S USE AMENDMENT FILED Loading...
May 24, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 29, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 4, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 4, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 14, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 1, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 25, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biotechnological platform technology, namely, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)
First Use Anywhere: May 5, 2023
First Use in Commerce: May 5, 2023

Classification

International Classes
005